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IV. ABSTRACT IN BAHASA MALAYSIA 
Pengenalan 
Hiperparatiroidisme sekunder merupakan satu penyakit yang sentiasa berlaku di 
kalangan pesakit buah pinggang dan ianya menpunyai simptom klinik yang berlainan.  
‘Total parathyroidectomy’ merupakan pembedahan terbaik untuk keadaan sebegini. Di 
antara komplikasi-komplikasi yang sentiasa berlaku selepas pembedahan ini ialah 
hipokalsiumia di kalangan pesakit yang menjalani pembedahan tersebut. 
 
Objektif 
Kajian ini untuk mengenalpasti faktor-faktor ramalan untuk meramal golongan 
pesakit yang akan menghadapi masalah hipokalsiumia selepas pembedahan. Objektif 
kedua adalah untuk mengenalpasti tanda-tanda hyperparathyroidism sekunder di 
kalangan pesakit buah pinggang. 
 
Kaedah 
Rekod pesakit buah pinggang yang menghadapi masalah hiperparatiroidisme 
sekunder yang menjalani pembedahan ‘total parathyroidectomy’ dari 1st Januari 2007 
sehingga 31st Desember 2014 akan dikaji.  Pesakit yang terlibat akan dibahagikan 
kepada 2 kumpulan berdasarkan tahap kalsium dalam darah didalam 24 jam pertama 
selepas pembedahan. Kumpulan hipokalsiumia (25 pesakit) dengan tahap kalsium 
2mmol/L dan kurang daripada 2mmol/L: Kumpulan kalsium normal (43 pesakit) 
dengan tahap kalsium lebih dari 2mmol/L. Faktor-faktor berkaitan seperti umur,jantina, 
tempoh buah pinggang rosak, keputusan darah sebelum operation seperti tahap kalsium, 
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tahap fosfat, tahap ‘alkaline phosphatase’, tahap ‘albumin’ , tahap ‘creatinine’ dan tahap 
paratiroid hormone akan dikaji dan dianalisis untuk mengenalpasti faktor ramalan bagi 
golongan pesakit yang berkecenderungan menghadapi komplikasi hipokalsiumia 
selepas pembedahan. Tanda-tanda hiperparatiroidisme sekunder di kalangan pesakit 
akan direkodkan.  
 
Keputusan 
Analisis logistik regrasi pelbagai menunjukkan tahap ‘alkaline phosphatase’ 
sebelum pembedahan ialah faktor ramalan berlakunya hipokalsiumia selepas 
pembedahan ‘total parathyroidectomy’ dengan nisbah ganjil 1.004. Kebanyakan pesakit 
yang menjalani pembedahan adalah golongan yang menpunyai tanda-tanda 
hiperparatiroidisme dengan 73% pesakit menghapai masalah sakit tulang and 21% 
pesakit menghadapi masalah lemah tubuh. Dua puluh lima pesakit (37%) menghadapi 
masalah hipokalsiumia selepas pembedahan “total parathyroidectomy”.  
 
Kesimpulan 
Tahap alkaline phosphatase sebelum pembedahan berkaitan rapat dengan 
kebarangkalian berlakunya komplikasi hipokalsiumia selepas pembedahan di kalangan 
pesakit hypertiroidisme sekunder. Pesakit yang menpunyai tahap alkaline phosphatase 
yang tinggi sebelum pembedahan seharusnya dipantau dengan lebih teliti dan  
menerima rawatan rapi pada fasa awal selepas pembedahan .   
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V.  ABSTRACT IN ENGLISH 
Background: 
Secondary Hyperparathyroidism (SHPT) in renal failure patients are common 
and had different clinical presentations. Total parathyroidectomy is the surgery of 
choice in this group of patient. Hypocalceamia or even hungry bone syndrome are well 
known and is one of the serious complication in post-parathyroidectomy patient. The 
objectives of this study are to identify the predictors of early post-operative 
hypocalcaemia after total parathyroidectomy as well as the clinical presentations of 
secondary hyperparathyroidism in renal failure patient. 
Methods: 
Renal failure patient with secondary hyperparathyroidism who had underwent 
total parathyroidectomy in between 1st January 2007 till 31st December 2014 were 
retrospectively reviewed. The patients were divided into 2 groups according to their 
serum calcium level within 24 hours post surgery: the Hypocalcaemia group (25 
patients) with post-operative serum calcium level of 2mmol/L or less, and the 
normocalcaemia group (43 patients), with the post-operative serum calcium level more 
then 2mmol/L. Patient details (age, gender and duration of renal failure) and pre-
operative blood investigations (preoperative serum calcium level ,  phosphorus level, 
alkaline phosphatase level ,serum albumin, serum intact parathyroid hormone and 
creatinine level) were analyzed in order to identify the predictor for early post-operative 
hypocalcaemia. The clinical presentations of secondary hyperparathyroidism in renal 
failure patient have also recorded.  
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Results: 
By using multiple logistic regression analysis, alkaline phosphatase (ALP) has 
predictive value for early post operative hypocalcaemia with adjusted Odd ratio 1.004. 
Most of the patient who underwent surgery is symptomatic pre-operatively and the 
common presentations were bone pain (73%) and muscle weakness (21%). 
Hypocalcaemia is common in renal hyperparathyrosim patient post total 
parathyroidectomy. Up to 37% of our patient suffered from this post op complication.  
 
Conclusion: 
In conclusion, preoperative serum alkaline phosphatase correlate positively with 
the development of early post-operative hypocalcaemia so patient with high pre-
operative alkaline phosphatase should be monitored more closely in the early post 
operative period.  
 
Keywords: Renal failure, secondary hyperparathyroidism, parathyroidectomy, 
hypocalcaemia, hungry bone syndrome 
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1-INTRODUCTION 
1.1- INTRODUCTION 
Hyperparathyroidism is a disease characterized by elevated serum calcium and 
inappropriate elevated parathyroid hormone (PTH) level. Prevalence for 
hyperparathyroidism is around 0.3% in general population.(1) 
There are 3 type of hyperparathyroidism -primary, secondary and tertiary. 
Secondary hyperparathyroidism (SHPT) refers to excessive secretion of parathyroid 
hormone in response to hypocalcaemia and associated hyperplasia of the parathyroid 
glands. SHPT will enhance vascular calcification with increased cardiovascular 
mortality.  
Chronic renal failure, hypermagnesiumia, osteoporosis and osteomalacia/ ricket 
can cause SHPT. By far the most common cause of SHPT is chronic renal failure but its 
clinical effects were not well elucidated until recently. Chronic renal failure or stage 5 
chronic kidney disease is defined as glomerular filtration rate (GFR) less then 
15ml/min/1.73m2 or requiring dialysis. Chronic renal failure patient with SHPT have 
variant presentation, range from completely asymptomatic to severe bone pain and 
pruritus. Patient also may present with osseous lesion such as fracture, growth 
retardation and osteitis cystica.  
Pathogenesis of secondary hyperparathyroidism is complex, involving every 
aspect of renal failure from the decreased synthesis function to metabolic abnormalities 
to even treatment of renal failure that can contribute to it. Factors that lead to 
hypertrophy and hyperplasia transformation of the parathyroid gland with subsequent 
elevation of PTH in an attempt to normalized serum calcium level are: 
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-Hyperphosphatamia and hypocalcemia 
-Reduce renal 1-alpha hydroxylase and calcitriol 
-Bony resistance to PTH (if excessive PTH) 
-Change in PTH set point (rise in set point) 
-Aluminium intoxication   
Initial treatment for SHPT is medical treatment with the aim to bringing the 
serum calcium and phosphate to a physiological level to prevent overstimulation of 
parathyroid glands and hence over production of parathyroid hormone. Medical therapy 
includes calcium supplement, vitamin D supplement, phosphate-poor diets, aluminium-
binding agents, haemodialysis with calcium enriched dialysate and calcimimetic agent  
eg, Cinacalcet. Surgical therapy for secondary hyperparathyroidism includes renal 
transplant (definite therapy) and operative parathyroidectomy. 
Despite the advent of the new therapeutic agents, patient with long term SHPT 
secondary to renal failure often require parathyrodectomy. Rate of parathyroidectomy 
has not changed significantly for the pass 20years despite the introduction of new 
medical therapy agents. Parathyroidectomy is indicated in patients who failed medical 
treatment, patients with intractable bone pain/pruritus, fracture and patients with 
symptomatic ectopic calcification 
Hypocalceamia or even hungry bone syndrome are well known and serious 
complication post-parathyroidectomy, but not all patient will develop this complication. 
So it will be very helpful and clinically significant if we can identify which patient is 
more prone to develop post operative hypocalcaemia/hungry bone syndrome in order to 
monitor them more closely during the early post-operative period. In this study, we 
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sought to identify the risk factors for developing early post-operative hypocalcaemia 
after total parathyroidectomy for secondary hyperparathyroidism. 
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1.2- LITERATURE REVIEW 
According to 21st REPORT OF THE MALAYSIAN DIALYSIS AND TRANSPLANT 
REGISTRY 2013, the number of new dialysis patients showed a linear increase over the 
last 10 years from 2901 patients in 2004 to 6541 patients in 2012 and at least 6222 
patients in 2013. The number of prevalent dialysis patients showed a steeper linear 
almost 12 thousand in 2004 to about 32 thousand in 2013. (2) 
Renal failure is associated with severe secondary hyperparathyroidism in majority 
of patient. Parathyroidectomy has an important role in the treatment of secondary 
hyperparathyroidism that is refractory to medical treatment. Post operative 
hypocalcemia is a well know and important complication after parathyroidectomy. (3, 4) 
Despite the advent of new therapeutic agents, patient with secondary 
hyperparathyroidism often required parathyroidectomy. Rate of parathyroidectomy did 
not change significantly between 1991 and 2001 despite progression in medical therapy 
with phosphate binder and vitamin D analogue. Overall parathyroidectomy is required 
in about 20% of patient after 3 to 10 years of dialysis and up to 40 % after 20 years. (5-7) 
Subtotal parathyroidectomy(SPTX) and total thyroidectomy with 
autotransplantation (TPTX +AT) was consider as  standard surgical procedures for 
hyperparathyroidism before this . But due to it higher recurrence rate, some author 
recommend total parathyroidectomy without autoimplantation (TPXT) as the standard 
procedure nowadays. (7) 
Recurrence rate of different parathyroidectomy approach: 
 SPTX  12% 
 TPXT+ AT 10% 
 TPXT  4% 
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Shih Ml et al concluded that total parathyroidectomy without autoimplantation 
for secondary hyperparathyroidism is the option for treating patient with 
symptomatic secondary hyperparathyroidism who are not expected to receive 
kidney transplantation.  In his study, 94 patients were assigned to 2 groups (44 
patients  in TPTX group, 50 patient in SPTX group) and recurrent rate was recorded. 
Recurrence rate over 60 months post op were significantly lower in TPTX group 
compare with SPTX group (4.5% Vs 18% respectively with p-value 0.028). There 
was no significant difference in term of post operative complication and symptom 
relief rate. (8) 
Incidence of post-operative hypocalcaemia among patients with primary 
hyperparathyroidism underwent parathyroidectomy has been reported to be 10 to 46% 
and among patient with secondary hyperparathyroidism has been reported to be up 
to 95%. Patient with secondary hyperparathyroidism develop more profound post-
operative hypocalcaemia so pre-operative predictor of hypocalcemia is particular 
important for postoperative management in patient with secondary 
hyperparathyroidism. (9) 
Many previous studies evaluating the predictor of postoperative hypocalcemia in 
patient with primary hyperparathyroidism, but there are limited data regarding 
predictors for secondary hyperparathyroidism. A regional study conducted by Loke 
SC et al.(10) involved 2 tertiary institutions (Tan Tock Seng Hospital Singapore and 
Kuala Lumpur General Hospital) show strong relationship between ALP and post 
operative hypocalcaemia in patients with primary hyperparathyroidism. Loke SC at 
al also recommended that pre-operative ALP to be used to complement clinical 
protocol for post –operative hypocalcemia management in parathyroidectomy 
patient. (10) 
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A study by Hamouda et al.(11) which involved 76 patients in Arab Saudi try to 
identify the risk factors for developing early post-operative hypocalcemia after 
parathyroidectomy for secondary hyperparathyroidism. In that study, Hamouda 
concluded that age, level of pre-operative calcium, alkaline phosphatase and serum 
albumin correlated with early post-operative hypocalcaemia. (11) 
Hypocalceamia or even hungry bone syndrome are well known and serious 
complication in patient post-parathyroidectomy especially in patient with secondary 
hyperparathyroidism, so it is clinically useful if we can identify some mean that reliably 
predicting it occurrence so that necessary preventive protocol can be devised in the 
future. 
 
1.3 - RATIONALE FOR THE STUDY 
 
Prevalence for Secondary hyperparathyrodism is increasing nowadays because 
number of patient with renal failure increased over the year in Malaysia.(12) To the best 
of our knowledge, there is no local study was done to identify risk factors for 
developing post operative hypocalcemia in patients with secondary 
hyperparathyroidism. As the consequences of post operative hypocalcemia are 
potentially serious, it is clinically useful if we can identify some mean that reliably 
predicting it occurrence so that necessary preventive protocol can be devised and 
reduced the incidence of post-operative hypocalcaemia.  
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Introduction 
Hyperparathyroidism is a disease characterized by elevated serum calcium and 
inappropriate elevated parathyroid hormone (PTH) level. Prevalence for 
hyperparathyroidism is around 0.3% in general population.(1) 
There are 3 type of hyperparathyroidism -Primary, Secondary and Tertiary. 
Secondary hyperparathyroidism (SHPT) refers to excessive secretion of parathyroid 
hormone in response to hypocalcaemia and associated hyperplasia of the parathyroid 
glands. SHPT will enhance vascular calcification with increased cardiovascular 
mortality.  
Chronic renal failure, hypermagnesiumia, osteoporosis and osteomalacia/ ricket 
can cause SHPT. By far the most common cause of SHPT is chronic renal failure but its 
clinical effects were not well elucidated until recently. Chronic renal failure or stage 5 
chronic kidney disease is defined as glomerular filtration rate (GFR) less then 
15ml/min/1.73m2 or required dialysis. Chronic renal failure patient with SPTH have 
variant presentation, range from completely asymptomatic to severe bone pain and 
pruritus. Patient also may present with osseous lesion such as fracture, growth 
retardation and osteitis cystica.  
Pathogenesis of secondary hyperparathyroidism is complex, every aspect of 
renal failure from the decreased synthesis function to metabolic abnormalities to even 
treatment of renal failure contribute to it. Factors that lead to hypertrophy and 
hyperplasia transformation of the parathyroid gland with subsequent elevation of PTH 
in an attempt to normalized serum calcium level such as: 
- Hyperphosphatamia and hypocalcemia 
- Reduce renal 1-alpha hydroxylase and calcitriol 
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- Bony resistance to PTH  (if excessive PTH) 
- Change in PTH set point (rise in set point) 
- Aluminium intoxication   
Initial treatment for SHPT is medical treatment with the aim to bringing the 
serum calcium and phosphate to a physiological level to prevent overstimulation of 
parathyroid glands and hence over production of parathyroid hormone. Medical therapy 
includes calcium supplement, vitamin D supplement, phosphate-poor diets, aluminium-
binding agents, haemodialysis with calcium enriched dialysate and calcimimeticagent  
eg, Cinacalcet. Surgical therapy for secondary hyperparathyroidism includes renal 
transplant (definite therapy) and operative Parathyroidectomy. 
Despite the advent of the new therapeutic agents, patient with long term SHPT 
secondary to renal failure often require parathyrodectomy. Rate of parathyroidectomy 
did not change significantly for the pass 20years despite the introduction of new 
medical therapy agents. Parathyroidectomy is indicated in patient who failed medical 
treatment, patient with intractable bone pain/pruritus, fracture and patient with 
symptomatic ectopic calcification. 
Hypocalceamia or even hungry bone syndrome are well known and serious 
complication post-parathyroidectomy, but not all patient will develop this complication. 
So it will be very helpful and clinically significant if we can identify which patient is 
more prone to develop post operative hypocalcaemia/hungry bone syndrome. 
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Rationale of this study 
• Prevalence for secondary hyperparathyrodism is increasing nowadays because 
patient with Renal failure patient increased over the year.(12) 
• No local study was done regarding risk factors for developing post operative 
hypocalcemia in secondary hyperparathyroidism. 
• As the consequences of post operative hypocalcemia are potentially serious, it is 
clinically useful if we can identify some mean that reliably predicting it 
occurrence so that necessary preventive protocol can be devised.  
 
Objective of study 
• To study the possible predictors of early post-operative hypocalcemia after 
parathyroidectomy and the clinical presentation of secondary 
hyperparathyroidism in renal failure patient.  
 
Specific objective  
• To identify the predictors for developing early post-operative hypocalcemia after 
parathyroidectomy for secondary hyperparathyroidismin in renal failure patients. 
• To determine the common clinical presentation of secondary 
hyperparathyroidism. 
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Research questions 
 Is there any factors (demographic or clinical) that can be use as predictors of 
early post-operative hypocalcemia after parathyroidectomy. 
 What is the common clinical presentation in patients with secondary 
hyperparathyroidism. 
 
Research hypothesis 
 Ho- Age, gender, clinical symptoms, length of dialysis, pre-operative blood 
investigation and are not associated with post-operative hypocalcemia after 
parathyroidectomy for secondary hyperparathyroidism.  
 HA- Age, gender , clinical symptom, length  of dialysis, pre-operative blood 
investigation are associated with post-operative hypocalcemia after 
parathyroidectomy for secondary hyperparathyroidism. 
 
 
 
 
 
 
 
 
 
 
 
 
12 
 
Literatures Review 
There is a linear increase of new dialysis patients over the last 10 years from 2901 
patients in year 2004 to 6541 patients in year 2012. The number of prevalent dialysis 
patients showed a steeper linear increment at almost 12 thousand patients in 2004 to 32 
thousand patients in 2013. (2) 
Renal failure is associated with severe secondary hyperparathyroidism in majority 
of patient. Parathyroidectomy has an important role in the treatment of secondary 
hyperparathyroidism that is refractory to medical treatment. Post operative 
hypocalcemia is a well know and important complication after parathyroidectomy. (3, 4) 
Despite the advent of new therapeutic agents, patient with secondary 
hyperparathyroidism often required parathyroidectomy. Rate of parathyroidectomy did 
not change significantly between 1991 and 2001 despite progression in medical therapy 
with phosphate binder and vitamin D analogue. Overall parathyroidectomy is required 
in about 20% of patient after 3 to 10 years of dialysis and up to 40 % after 20 years. (5-7) 
Subtotal parathyroidectomy(SPTX) and total thyroidectomy with 
autotransplantation (TPTX +AT) was consider as  standard surgical procedures for 
hyperparathyroidism before this . But due to it higher recurrence rate, some author 
recommend total parathyroidectomy without autoimplantation (TPXT) as the standard 
procedure nowadays. (7) 
Recurrence rate of different parathyroidectomy approach: 
 SPTX  12% 
 TPXT+ AT 10% 
 TPXT  4% 
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Shih Ml et al concluded that total parathyroidectomy without autoimplantation 
for secondary hyperparathyroidism is the option for treating patient with 
symptomatic secondary hyperparathyroidism who are not expected to receive 
kidney transplantation.  In his study, 94 patients were assigned to 2 groups (44 
patients  in TPTX group, 50 patient in SPTX group) and recurrent rate was recorded. 
Recurrence rate over 60 months post op were significantly lower in TPTX group 
compare with SPTX group (4.5% Vs 18% respectively with p-value 0.028). there 
was no significant difference in term of post operative complication and symptom 
relief rate. (8) 
Incidence of post-operative hypocalcaemia among patients with primary 
hyperparathyroidism underwent parathyroidectomy has been reported to be 10 to 46% 
and among patient with secondary hyperparathyroidism has been reported to be up 
to 95%. Patient with secondary hyperparathyroidism develop more profound post-
operative hypocalcaemia so pre-operative predictor of hypocalcemia is particular 
important for postoperative management in patient with secondary 
hyperparathyroidism. (9) 
Many previous studies evaluating the predictor of postoperative hypocalcemia in 
patient with primary hyperparathyroidism, but there are limited data regarding 
predictors for secondary hyperparathyroidism. A regional study conducted by Loke 
SC et al.(10) involved 2 tertiary institutions (Tan Tock Seng Hospital Singapore and 
Kuala Lumpur General Hospital) show strong relationship between ALP and post 
operative hypocalcaemia in patients with primary hyperparathyroidism. Loke SC at 
al also recommended that pre-operative ALP to be used to complement clinical 
protocol for post –operative hypocalcemia management in parathyroidectomy 
patient. (10) 
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A study by Hamouda et al which involved 76 patients in Arab Saudi try to 
identify the risk factors for developing early post-operative hypocalcemia after 
parathyroidectomy for secondary hyperparathyroidism. In that study, Hamouda 
concluded that age, level of pre-operative calcium, alkaline phosphatase and serum 
albumin correlated with early post-operative hypocalcaemia. (11) 
Hypocalceamia or even hungry bone syndrome are well known and serious 
complication in patient post-parathyroidectomy especially in patient with secondary 
hyperparathyroidism, so it is clinically useful if we can identify some mean that reliably 
predicting it occurrence so that necessary preventive protocol can be devised in the 
future. 
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Methodology 
Research design 
This is a retrospective study involving patients with secondary hyperparathyroidism that 
underwent parathyroidectomy in Hospital Raja PerempuanZainab II from 1st January 
2007 to 31st December 2014. 
Source population  
The study includes all renal failure patients with secondary hyperparathyroidism who 
underwent parathyroidectomy from 1st January 2007 to 31st December 2014 in Hospital 
Raja Perempuan Zainab II. The list of patients who underwent parathyroidectomies will 
be traced from the record in the operation theater. The data collection will be started 
after ethical approval. 
Sampling frame  
All patients that fulfilled the inclusion and exclusion criteria will be recruited  
• Inclusion criteria: 
– All renal failure patients with secondary hyperparathyroidism who 
underwent total parathyroidectomy during the duration of study.  
• Exclusion criteria: 
– Patients with renal hyperparathyroidism who underwent 
parathyroidectomy with incomplete data or missing data  
– Patient younger than 16 years old was excluded  (have higher 
physiological alkaline phosphatase level ) 
Sampling methods  
Convenient sampling 
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Sample size calculation 
Sample size for research question  
Sample size calculations were performed using PS software. “Studies that are analyzed 
by t-test with independent design” were chosen. 
 
1. Associated factor : Age 
δ = expected detectable difference between two groups  
σ = standard deviation of either group 
α = 0.05  Power of study = 80%     n = required sample size           
m = ratio of patients of hypocalcaemia to normo-calcaemia(1 : 1) 
Torer et.al1 reported the mean age of patients in the hypocalcaemia group are 
younger than those in the normo-calcaemia group (36.0± 9.7 versus 49.2 ± 
13.2,p=0.006)  
σ  = 9.7  δ = 13  
 
Result of sample size calculation show that we will need 10 subjects for each group. 
Utilizing 10% for drop out, the minimum sample size for each group is 11 subjects 
(which is equivalent with 22 subjects for the whole study). 
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2. Associated factor : pre operative Calcium level 
δ = expected detectable difference between two groups  
σ = standard deviation of either group 
α = 0.05  Power of study = 80%     n = required sample size           
m = ratio of patients of hypocalcaemia to Normo-calcaemia(1 : 1) 
Torer et.al1 reported the pre-operative Ca level (≤2.0mmol) of patients in the 
hypocalcaemia group developed hypocalcaemia compared to normo-calcaemia group   
duringpost operative (9.6± 0.7versus 10.4± 1.1,p=0.01)  
σ  = 0.7  δ = 0.8 
 
Result of sample size calculation show that we will need 13 subjects for each group. 
Utilizing 10% for drop out, the minimum sample size for each group is 15 subjects 
(which is equivalent with 30 subjects for the whole study). 
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3. Associated factor : ALP 
δ = expected detectable difference between two groups  
σ = standard deviation of either group 
α = 0.05  Power of study = 80%     n = required sample size           
m = ratio of patients of hypocalcaemia to normo-calcaemia(1 : 1) 
Hamoudaet.al reported the mean and SD pre-operative ALP level for  
both group is 1100 ± 112, σ  = 112  δ = 100  
 
Result of sample size calculation show that we will need 21 subjects for each group. 
Utilizing 10% for drop out, the minimum sample size for each group is 24 subjects 
(which is equivalent with 48 subjects for the whole study). 
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4. Associated factor : Albumin 
δ = expected detectable difference between two groups  
σ = standard deviation of either group 
α = 0.05  Power of study = 80%     n = required sample size           
m = ratio of patients of hypocalcaemia to normo-calcaemia(1 : 1) 
Hamouda et.al2 reported the mean and SD pre-operative Albumin level for  
both groups is 37.2 ± 2.58 
σ  = 2.58  δ = 2.1 
 
Result of sample size calculation show that we will need 25 subjects for each group. 
Utilizing 10% for drop out, the minimum sample size for each group is 28 subjects 
(which is equivalent with 56 subjects for the whole study). 
 
The highest sample size calculation will be chosen for the study. In this 
case, the total sample size required for both groups will be 56 subjects 
(28 subjects for each arm). 
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Study Conduct 
- After ethical approval, a list of patients who underwent  parathyroidectomy in between 
January 2007 to December 2014 will be obtained from the record in the operation 
theater Hospital Raja Perempuan Zainab II. 
- Patients who fulfill the inclusion and exclusion criteria will be recruited in the study.  
- The data of patients will be obtained by retrospective study of patients’ medical 
records. The data will be entered in a data collection form (Appendix 1)   
-  Clinical and biochemical parameters of eligible subjects will be recorded using a pre-
tested data collection form. The variables of interest are age, gender, ethnicity, duration 
of dialysis, main complaint, occurrence of renal hyperparathyroidism, pre- and post-
operative blood investigation, post-operative calcium level as well as operative 
information. 
- Patients will be divided into two groups based on the post operative calcium level 
within 24 hour according to the definition proposed by Hamouda et al. 
 Normocalcemia (more than 2mmol/L) and  
 Hypocalcemia (2mmol/L or <2mmol/L) group. 
- Data analysis using SPSS software. All results are expressed as mean value, standard 
deviation and percentage. 
- P-value less than 5% were accepted to be significant  
-Univariate statistical tests using simple logistic regression will be performed and P-
value less then 5% will be accepted to be significant. Multivariate stepwise logistic 
regression will be use to identify predictive factors of early hypocalcemia  
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Privacy and confidentiality 
 
Personal information and data will not be disclosed unless required by law. 
Subject’s confidentiality will be protected, no name or identifiable information will be 
collected. The data collection form will have serial numbers instead of names of the 
subjects to prevent recognition. 
Data will be protected through password setting to access the database and 
securely locked. The data is only accessible by researchers involve in this study. The 
data will be used and remain directly available up to completion of the study. Thereafter, 
the data will be compressed with encryption and archived in a flash drive after proper 
documentation. This is to destroyed by formatting the flash drive after a 3-years 
maintenance period determined by the date of its formal closure. We define the formal 
closure as the submission of a closure report to the National Medical Research Registry 
of Malaysia. 
Subject’s data and information will be kept confidential and will be known by 
research team only. Only aggregated (grouped) results will be presented and submitted 
to local or international peer-reviewed medical journals and relevant government 
ministries. 
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Flow chart 
 
List of patients underwent parathyroidectomy between year 2007 to 2014 obtained 
from operation theater. 
↓ 
 Recruitment of patients who fulfilling the inclusion and exclusion criteria  
↓ 
Review of medical records of patients that recruited in the study 
↓ 
Data from medical records entered in the data collection form 
↓ 
Data collection and statistical analysis 
↓ 
Report and manuscript write up 
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Gantt Chart of Research Activities 
PROJECT 
ACTIVITIES 
2015 2016 
Research 
Activities 
J F M A M J J A S O N D J F M A M J J A S O N D 
Dissertation 
topic 
discussion at 
department and 
Ethic approval 
                        
Patient / 
Subjects 
Recruitmentand 
Data Collection 
                        
Data Analysis / 
Interpretation 
                        
Presentation & 
Submission of 
Reports 
                
 
 
       
Report Writing                         
Submission of 
dissertation 
Papers 
                        
 
Milestone of Research Activities:  
June 2015 :Proposal preparation and presentation 
March 2016 : Starting patient recuitment and Date collection  
April  2016 : Completion of data collection 
May  2016 : Completion of data analysis 
May  2016 : Preparation of dissertation write up   
July  2016 : Dissertation paper submission 
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Appendices  
Appendix 1: Data Collection Form     Sample no : _______  
Demographic: 
Age: __________ Sex: M/ F       Ethnic: _____________ 
Pre-operative information: 
 
1. Main complaint 
o Renal stone 
o Bone pain 
o Polyuria/polydispsia 
o Nausea/vomiting 
o Constipation 
o Pancreatitis 
o Peptic ulcer 
o Muscle weakness 
o Psychosis 
Duration of symptom: ___________months 
 
2. Renal hyperparathyroidism 
 
• Duration of renal failure: ___________years 
• Duration of haemodialysis: ____________years 
• Evidence of aluminium bone disease Y/N 
 
3. Pre-operative investigation 
Serum calcium ________mmol/L 
Serum albumin________g/L 
Serum phosphate _______mmol/L 
Serum ALP ________IU/L 
Serum iPTH _________pg/ml 
Serum creatinine ______umol/L 
 
 
 
Operative information: 
Date of surgery: ____________  
 
Weight of resected specimen: _____g HPE result :____________ 
 
 
